rahulg1122

[rahulg1122]

The global contrast media injectors market size is estimated to be USD 1.3 billion in 2020 and projected to reach USD 1.9 billion by 2025, at a CAGR of 7.4% between 2020 and 2025.

[rahulg1122]

Surgical Sealants and Adhesives Market Worth $2.8 Billion by 2025 - Exclusive Report by MarketsandMarkets™

According to the new market research report "Surgical Sealants and Adhesives Market by Product (Natural (Fibrin, Collagen, Gelatin), Synthetic (Hydrogel)), Indication (Tissue Sealing, Tissue Engineering), Application (CNS, Cardiovascular, Cosmetic Surgery), End User - Global Forecast to 2025", published by MarketsandMarkets™, the Surgical Sealants and Adhesives Market is expected to reach USD 2.8 billion in 2025 from USD 1.9 billion in 2020, at a CAGR of 8.4% during the forecast period.

Request for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38230314

The growing concerns regarding the effective management of blood loss in patients during surgeries and trauma, surgical sealants and adhesives have become an integral part of medical procedures. Also, the growing prevalence and incidence rates of various disorders such as obesity and CVDs; increasing incidence of trauma; growth in the number of accidents and sports-related injuries, which has led to an increase in surgical procedures being performed across the globe are factors driving the market growth. Better cosmetic outcomes are also increasing the adoption of surgical sealants and adhesives in cosmetic procedures across the globe. The growing prominence of adhesive dentistry also offers significant growth opportunities for players operating in this space.

By product, the natural/biological sealants and adhesives segment is expected to account for the largest share of the Surgical Sealants Market

Based on product, the Surgical Adhesives Market is segmented into natural/biological sealants and adhesives and synthetic & semisynthetic sealants and adhesives. The natural/biological sealants and adhesives segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the fact that sealants derived from natural polymers provide superior biocompatibility, reduced immune response, and in vivo degradability as compared to synthetic sealants; and are used to repair injured tissues and reinforce surgical wounds, having replaced common suturing techniques.

Browse in-depth TOC on "Surgical Sealants and Adhesives Market" 264 – Tables 49 – Figures 273 – Pages

Tissue sealing dominated the Surgical Adhesives Market in 2019

By indication, the tissue sealing segment accounted for the largest share of the Surgical Sealants Market, followed by surgical hemostasis and tissue engineering in 2019. The large share of the tissue sealing segment can be attributed to the increasing use of tissue sealants and glues with the increasing number of surgeries being performed annually the need to manage blood loss during these procedures, and the growing number of people suffering from sports-related injuries.

The cardiovascular surgery segment is expected to witness the rising adoption of biosurgery products during the forecast period

By application, the cardiovascular surgery segment accounted for the largest share of the Surgical Adhesives Market, followed by general surgery, and CNS surgery in 2019. The large share of the cardiovascular surgery segment is attributed to the increasing use of sealants and adhesives in CVD surgeries to overcome the challenges such as friable tissue, coagulopathy, poor visualization of the surgical field, and poor bleeding-site accessibility. Surgical sealants also help stop bleeding from adhesions at the time of re-operative cardiac surgery and from diffuse surfaces with capillary bleeding. With the increasing incidence of CVDs due to rising obesity and lifestyle-related disorders, the diagnostic and therapeutic procedures are set to increase, thereby leading to the growing adoption of sealants and adhesives.

Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=38230314

Hospitals to increase the adoption of biosurgery products with increasing surgical procedures being undertaken

Based on end users, the Surgical Sealants And Adhesives Market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, burn care centers, and research institutes). The hospitals segment is estimated to grow at the highest CAGR during the forecast period. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the rising adoption of sealants and adhesives by surgeons. The low cost of these products along with their ease of use and lower risk of complications, offer significant advantages, further supporting market growth.

North America to dominate the Surgical Sealants Market during the forecast period

In 2019, North America dominated the global Surgical Adhesives Market, followed by Europe. The large share of North America can be attributed to the significant growth opportunities for players operating in the market owing to the presence of many large hospitals and an increasing number of surgical procedures in this region. Moreover, a number of major global players are based in the US, owing to which the US is a center for innovation in the market.

The prominent players in this Surgical Sealants Market are Baxter International, Inc. (US), CryoLife, Inc. (US), Becton, Dickinson and Company [C.R Bard (US)], Ethicon, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Integra Lifesciences Holdings Corporation (US), Medline Industries, Inc. (US), Adhezion Biomedical, LLC (US), Tricol Biomedical, Inc. (US), Vivostat A/S (Denmark), Advanced Medical Solutions Group plc (UK), Stryker Corporation (US), CSL Limited (Australia), Ocular Therapeutix, Inc. (US), MicroVal (France), GEM Srl (Italy), Hemostasis, LLC (US), Péters Surgical (France), and Tissuemed Ltd (UK).

[rahulg1122]

The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026.

[rahulg1122]

Parkinson's Disease Treatment Market Worth 5.69 Billion USD by 2022

According to a new market research report "Parkinson's Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 5.69 Billion by 2022 from USD 4.24 Billion in 2017, at a CAGR of 6.1%. 

Browse 66 Market Data Tables and 33 Figures spread through 113 Pages and in-depth TOC on "Parkinson's Disease Treatment Market" 

The market is being driven by the growth in aging population and the associated increase in the prevalence of Parkinson's disease and government funding for research.

By drug class, the carbidopa/levodopa segment is estimated to dominate the market in 2017 

On the basis of drug class, the Parkinson's disease therapeutic drugs market is segmented into carbidopa/levodopa, dopamine receptor agonists, MAO inhibitors, COMT inhibitors, anticholinergics, and other drugs. In 2017, the carbidopa/levodopa segment is expected to account for the largest share of the market. Carbidopa/levodopa drugs are more potent than most other drug classes are hence widely used in the treatment of Parkinson's disease.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=47265247

By distribution channel, the hospital pharmacies segment is estimated to hold the largest share of the market in 2017 

By distribution channel, the Parkinson's disease therapeutic drugs market has been segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. In 2017, the hospital pharmacies segment is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to the availability of a wide range of drugs in these facilities and the increasing number of patient visits to hospitals.

Hospitals to dominate the Parkinson's Disease Treatment Market during the forecast period 

The Parkinson's Disease Treatment Market is classified by patient care settings into hospitals and clinics. In 2017, the hospital segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to clinics segment. This market is mainly driven by robust healthcare services provided in hospitals and the presence of skilled neurologists in the hospitals.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=47265247

Asia to offer lucrative growth opportunities 

By region, the global Parkinson's Disease Treatment Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While Europe is expected to hold the largest share of the market in 2017, Asia is expected to grow at the highest CAGR during the forecast period. Increasing number of players in the region and the rising aging population are some major factors driving the high growth of this regional segment.

Some of the major players operating in the Parkinson's disease treatment market include Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), Boehringer Ingelheim (Germany),  Impax Laboratories (US), Lundbeck (Denmark), Sun Pharma (India), Wockhardt (India), UCB (Belgium), Valeant Pharmaceuticals (Canada), and Acadia (US).

[rahulg1122]

The negative pressure wound therapy market is expected to reach USD 2, 724.2 million by 2023, from USD 2,113.6 million in 2018, at a CAGR of 5.2%.

[rahulg1122]

Surgical Sealants and Adhesives Market Worth $2.8 Billion by 2025

According to the new market research report "Surgical Sealants and Adhesives Market by Product (Natural (Fibrin, Collagen, Gelatin), Synthetic (Hydrogel)), Indication (Tissue Sealing, Tissue Engineering), Application (CNS, Cardiovascular, Cosmetic Surgery), End User - Global Forecast to 2025", published by MarketsandMarkets™, the Surgical Sealants and Adhesives Market is expected to reach USD 2.8 billion in 2025 from USD 1.9 billion in 2020, at a CAGR of 8.4% during the forecast period.

Request for PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=38230314

The growing concerns regarding the effective management of blood loss in patients during surgeries and trauma, surgical sealants and adhesives have become an integral part of medical procedures. Also, the growing prevalence and incidence rates of various disorders such as obesity and CVDs; increasing incidence of trauma; growth in the number of accidents and sports-related injuries, which has led to an increase in surgical procedures being performed across the globe are factors driving the market growth. Better cosmetic outcomes are also increasing the adoption of surgical sealants and adhesives in cosmetic procedures across the globe. The growing prominence of adhesive dentistry also offers significant growth opportunities for players operating in this space.

By product, the natural/biological sealants and adhesives segment is expected to account for the largest share of the Surgical Sealants Market

Based on product, the Surgical Adhesives Market is segmented into natural/biological sealants and adhesives and synthetic & semisynthetic sealants and adhesives. The natural/biological sealants and adhesives segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the fact that sealants derived from natural polymers provide superior biocompatibility, reduced immune response, and in vivo degradability as compared to synthetic sealants; and are used to repair injured tissues and reinforce surgical wounds, having replaced common suturing techniques.

Browse in-depth TOC on "Surgical Sealants and Adhesives Market"

264 – Tables

49 – Figures

273 – Pages

Tissue sealing dominated the Surgical Adhesives Market in 2019

By indication, the tissue sealing segment accounted for the largest share of the Surgical Sealants Market, followed by surgical hemostasis and tissue engineering in 2019. The large share of the tissue sealing segment can be attributed to the increasing use of tissue sealants and glues with the increasing number of surgeries being performed annually the need to manage blood loss during these procedures, and the growing number of people suffering from sports-related injuries.

The cardiovascular surgery segment is expected to witness the rising adoption of biosurgery products during the forecast period

By application, the cardiovascular surgery segment accounted for the largest share of the Surgical Adhesives Market, followed by general surgery, and CNS surgery in 2019. The large share of the cardiovascular surgery segment is attributed to the increasing use of sealants and adhesives in CVD surgeries to overcome the challenges such as friable tissue, coagulopathy, poor visualization of the surgical field, and poor bleeding-site accessibility. Surgical sealants also help stop bleeding from adhesions at the time of re-operative cardiac surgery and from diffuse surfaces with capillary bleeding. With the increasing incidence of CVDs due to rising obesity and lifestyle-related disorders, the diagnostic and therapeutic procedures are set to increase, thereby leading to the growing adoption of sealants and adhesives.

Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=38230314

Hospitals to increase the adoption of biosurgery products with increasing surgical procedures being undertaken

Based on end users, the Surgical Sealants And Adhesives Market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, burn care centers, and research institutes). The hospitals segment is estimated to grow at the highest CAGR during the forecast period. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the rising adoption of sealants and adhesives by surgeons. The low cost of these products along with their ease of use and lower risk of complications, offer significant advantages, further supporting market growth.

North America to dominate the Surgical Sealants Market during the forecast period

In 2019, North America dominated the global Surgical Adhesives Market, followed by Europe. The large share of North America can be attributed to the significant growth opportunities for players operating in the market owing to the presence of many large hospitals and an increasing number of surgical procedures in this region. Moreover, a number of major global players are based in the US, owing to which the US is a center for innovation in the market.

The prominent players in this Surgical Sealants Market are Baxter International, Inc. (US), CryoLife, Inc. (US), Becton, Dickinson and Company [C.R Bard (US)], Ethicon, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Integra Lifesciences Holdings Corporation (US), Medline Industries, Inc. (US), Adhezion Biomedical, LLC (US), Tricol Biomedical, Inc. (US), Vivostat A/S (Denmark), Advanced Medical Solutions Group plc (UK), Stryker Corporation (US), CSL Limited (Australia), Ocular Therapeutix, Inc. (US), MicroVal (France), GEM Srl (Italy), Hemostasis, LLC (US), Péters Surgical (France), and Tissuemed Ltd (UK).

[rahulg1122]

Some of the players in the neurodiagnostics market are GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Canon, Inc. (Japan), Hitachi, Ltd. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US)

[rahulg1122]

Vascular Closure Devices Market worth $1.3 billion by 2026

According to the new market research report "Vascular Closure Devices Market by Type (Passive Approximators, Active Approximators, External Hemostatic Devices), Access (Femoral, Radial), Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery) - Global Forecast to 2026", published by MarketsandMarkets™, the global Vascular Closure Devices Market is projected to USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 7.0% during the forecast period.

Browse in-depth TOC on "Vascular Closure Devices Market"

151 – Tables

31 – Figures

183 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180101468

Large number of approvals for vascular closure devices, high prevalence of cardiovascular diseases, increasing prevalence of obesity, increasing focus of market players on large-bore vascular closure devices, growing geriatric population, favorable reimbursement scenario for interventional radiology procedures, and rising focus on effective blood loss management in patients during surgeries are the major factors driving the growth of the vascular closure devices market.

The passive approximators segment is expected to grow at the highest CAGR during the forecast period and accounted for the largest share in 2020.

Based on type, the vascular closure devices market is segmented into passive approximators, active approximators, and external hemostatic devices. Passive approximators account for the largest share of the vascular closure devices market. The large share of this segment can be attributed to the increasing number of approvals for vascular closure devices and the wide range of advantages associated with these devices, such as ease of use and reduced complication rate in patients.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=180101468

North America was the largest regional market for the vascular closure devices market in 2020

The vascular closure devices market is segmented into North America (the US and Canada), Europe (E-3, and the Rest of Europe), Asia Pacific, and Rest of World. In 2020, North America dominated the global vascular closure devices market, followed by Europe. The large share of the North American market can be attributed to the rising prevalence of cardiovascular diseases, the growing trend of one-day surgeries for vascular procedures, increasing research and clinical trials for vascular closure devices in the US, the increasing number of cardiac arrest cases, and the long waiting periods for cardiac surgeries (which encourage the adoption of minimally invasive procedures) in Canada.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=180101468

The global vascular closure devices market is consolidated. The prominent players operating in this market include Terumo Corporation (Japan), Abbott (US), Cardinal Health (US), Cardiva Medical, Inc. (US), Medtronic Plc (Ireland), Morris Innovative, Inc. (US), Teleflex Incorporated (US), Merit Medical Systems, Inc. (US), Vasorum Ltd. (Ireland), TZ Medical, Inc. (US), Vivasure Medical Ltd. (Ireland), Tricol Biomedical (US), Scion Biomedical (US), Advanced Vascular Dynamics (US), Marine Polymer Technologies, Inc. (US), and Rex Medical (US).

[rahulg1122]

The prosthetic heart valve market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9%.

[rahulg1122]

Veterinary Pain Management Market Worth 1.66 Billion USD by 2023

According to a new market research report "Veterinary Pain Management Market by Product (Drugs (NSAIDs, Opioids), Device (Laser, Electromagnetic), Application (Osteoarthritis, Cancer), Animal Type (Dog, Cat, Horse, Cattle), Distribution Channel (Hospital, Pharmacy)) - Global Forecast to 2023", published by MarketsandMarkets™, the market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and the rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. 

Browse 232 market data Tables and 45 Figures spread through 237 Pages and in-depth TOC on "Veterinary Pain Management Market"  

Get a Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=96167677

By drug type, disease-modifying osteoarthritis agents are expected to grow at the highest CAGR during 2018-2023 

Based on drug type, the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), opioids, alpha-2 agonists, local anesthetics, disease-modifying osteoarthritis agents (DMOAAs), and other drugs. The DMOAAs segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment can be attributed to the high prevalence of arthritis in animals. However, NSAIDs are expected to hold the largest share in the market due to their wide range of applications areas and low cost.

By application, joint pain accounted for the largest market share in 2017 

Based on application, the Veterinary Pain Management Market has been segmented into joint pain, postoperative pain, cancer, and other applications. Other applications include traumatic pain, abdominal pain, neuropathic pain, dermatological pain, and mastitis. In 2017, joint pain held the largest share of the Veterinary Pain Management Market. The dominant share of this application segment has been attributed to the growing pet population, raising prevalence of osteoarthritis and musculoskeletal disorders in animals, and the increasing population of obese and overweight pets.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=96167677

Veterinary hospitals & clinics are expected to be the largest distribution channel for veterinary pain management products in 2017. 

Based on distribution channels, the Veterinary Pain Management Market is segmented into hospitals & clinics and pharmacies. In 2017, veterinary hospitals & clinics accounted for a larger market share than pharmacies primarily due to factors such as the increasing number of veterinary clinics and hospitals, growing ownership of companion animals, and increasing veterinary expenditure.

APAC is expected to grow at the highest CAGR during the forecast period. 

Global Veterinary Pain Management Market has been studied for North America, Europe, Asia Pacific (APAC), Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in Veterinary Pain Management Market, primarily due to the significant growth in pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China.

The prominent players in the Veterinary Pain Management Market are Zoetis (US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the Veterinary Pain Management Market

[rahulg1122]

The global injection pens market is projected to reach USD 53.3 billion by 2026 from USD 37.6 billion in 2021, at a CAGR of 7.2% during the forecast period.

[rahulg1122]

Dental Imaging Market Worth $4.1 Billion by 2025

According to the new market research report "Dental Imaging Market by Product (CBCT, Intraoral X ray, Intraoral Cameras, Intraoral Scanners), Application (Oral and Maxillofacial Surgery, Implantology) & End user (Dental Hospitals & Clinics, Dental Diagnostic Centers) - Global Forecast to 2025", published by MarketsandMarkets™, the Dental Imaging Market is projected to reach USD 4.1 billion by 2025 from USD 2.6 billion in 2020, at a CAGR of 9.0%.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=109621591

In the current global scenario-where the focus on technological advancements has risen-it is expected that the benefits of advanced dental imaging will ensure its greater adoption in the years to come. The rising demand for cosmetic dentistry, the growing affordability of imaging systems, and the need for rapid and accurate diagnosis are the other major factors driving the growth of this market.

The intraoral scanners segment is projected to grow at the highest CAGR during the forecast period.

The market is segmented into extraoral and intraoral imaging systems. The intraoral imaging systems segment is further divided into intraoral X-ray systems, intraoral sensors, intraoral PSP systems, intraoral scanners, and intraoral cameras. Intraoral scanners are projected to grow at the highest growth rate during the forecast period, driven by the advantages of capturing direct dental impressions, reducing the rate of restoration remakes, and providing overall better clinical workflows.

Implantology to hold the largest share in the dental imaging market.

The market is further segmented into implantology, oral & maxillofacial surgery, endodontics, orthodontics, and other applications. The implantology segment commanded the largest share of the market in 2019. The large share of this segment can be attributed to the growing adoption of dental implants, increasing number of bone-graft assessments, and rising focus on the evaluation of post-treatment cases.

Browse in-depth TOC on "Dental Imaging Market"

150 – Tables

30 – Figures  

183 – Pages

Dental hospitals & clinics to register the highest growth rate during the forecast period.

The market is broadly classified into dental hospitals & clinics, dental diagnostic centers, and dental academic & research institutes. Dental hospitals & clinics are expected to witness the highest growth rate during the forecast period. The high growth rate of this end-user segment can be attributed to the rising affordability of advanced dental imaging systems, growing patient awareness, and increasing need for rapid and accurate patient diagnosis and treatment planning.

Get 10% Customization on this Research Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=109621591

North America holds the largest share in the dental imaging market.

North America held the largest share of the market in 2019. This is due to the presence of a large number of players in the dental imaging market, increasing awareness among patients, and the rising adoption of technically advanced imaging systems by dentists. The Asia Pacific region, on the other hand, witnessed the highest growth, which is driven by factors such as the increasing focus of emerging and leading market players on developing Asian markets, rise in disposable incomes, comparatively lenient regulatory guidelines, and growing dental tourism market.

The prominent players in the global dental imaging market are Envista Holdings Corporation (US), PLANMECA OY (Finland), ACTEON Group (UK), DENTSPLY Sirona (US), Carestream Dental, LLC (US), VATECH Co. Ltd. (South Korea), Owandy Radiology (France), DÜRR DENTAL SE (Germany), Midmark Corporation (US), Genoray Co. Ltd. (South Korea), Asahi Roentgen Co. Ltd. (Japan), 3Shape (Denmark), PreXion, Inc. (US), Ningbo Runyes Medical Instrument Co. Ltd.(China), Cefla Medical Equipment (Italy), Apteryx Imaging (Canada), Yoshida Dental Mfg. Co. Ltd. (Japan), Align Technology Inc. (US), J. MORITA CORP (Japan), and FONA Italy (Italy).

[rahulg1122]

The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from an estimated USD 857.8 million in 2018, at a CAGR of 6.4%.

[rahulg1122]

Mice Model Market worth $1.9 billion by 2025

According to the new market research report "Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic testing), Care Products (Cages, Bedding, Feed), Region - Global Forecast to 2025", published by MarketsandMarkets™, is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period.

Browse and in-depth TOC on "Mice Model Market"

295 - Tables

29 - Figures

263 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1308 

The Market growth is driven mainly by the ongoing innovations in mice models, continuous support in the form of investments and grants from the government & private sectors, and increased demand for humanized mice models due to the growing consumption of personalized medicine.

Inbred mice accounted for the largest share in the Mice Model Market in 2019.

Based on the mice type, the market is categorized into the inbred mice, outbred mice, conditioned/surgically modified mice, hybrid/congenic mice, genetically engineered mice, and spontaneous mutant mice segments.  The inbred mice segment accounted for the largest share of the market in 2019. The increasing use of inbred mice for the production of monoclonal antibodies, growing research application of inbred mice in pharmacology and cardiovascular disease studies, are the primary factors driving the growth of this segment.

Oncology Studies accounted for the largest share in the Mice Model Market in 2019

Based on application, the market has been segmented into oncology studies, immunology and inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system studies (CNS), genetic studies, infectious disease studies, and other disease studies. The endocrine disease studies segment is further segmented into diabetes and other endocrine metabolic disease. Oncology studies accounted for the largest share of the market in 2019. Increasing prevalence of cancer, a large number of research activities in the field of cancer, and growing implications of mice models in the study of various cancers are expected to drive market growth.

Breeding  accounted for the largest share the market in 2019

Based on services, the market is segmented into breeding, quarantine, cryopreservation, rederivation, genetic testing, model in-licensing, and other services (surgical, line rescue, and in vivo pharmacology services). Of all these segments, the breeding services segment accounted for the largest share of the Mice Model Market in 2019. The use of mice models for biomedical and pharmaceutical research has resulted in a growing need for expertise in breeding mutant, transgenic, gene-targeted, and other types of mice. As a result, several companies are providing breeding and other related services to meet growing demand.

CRISPR/Cas9 accounted for the largest share of the market

Based on the type of technology used to create transgenic mice, the Mice Model Market is categorized into the CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (includes virus/vector-mediated gene transfer, and TALENs & ZFNs) segments. CRISPR is the most widely used technology in the market and contributed to the largest share of the market in 2020. Ease of design, high efficiency, and relatively lower cost have increased the demand for CRISPR-customized mice models.

Get 10% Customization Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1308 

Cages segment accounted for the largest share of the Mice Model Market

Based on mice care products, the market has been segmented into cages, feed, bedding, and other products (gnotobiotic equipment, water systems, and accessories). In 2019, the cages segment accounted for the largest share of the market. This can be attributed to the availability of a wide range of cages designed for specific research needs and the higher cost of cages compared to other care products.

North America accounted for the largest share of the Mice Model Market in 2019.

Based on the region, the global market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the market. The large share of the North America region can be attributed to the presence of major players operating in the market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.

The major players operating in this Mice Model Market Charles River Laboratories, (US) The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (US), JANVIER LABS (France), genOway (France), PolyGene (Switzerland), Crown Biosciences (US), TransCure Bioservices (France), Ingenious Targeting Laboratory (US), Cyagen Biosciences (US), GVK BIO (India), The Andersons, Inc. (US), Innovive (US), Allentown, LLC (US), FENGSHI Group (China), Ozgene Pty Ltd. (Australia), Harbour Biomed (US) among others

[rahulg1122]

The operating room integration market is projected to reach USD 1.7 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 12.4%.

[rahulg1122]

Immunohistochemistry (IHC) Market worth $3.3 billion by 2026

According to the new market research report "Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End user (Hospitals, Diangostic labs, Academia) - Global Forecast to 2026", published by MarketsandMarkets™, the global IHC Market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period.

Browse in-depth TOC on "Immunohistochemistry Market" 342 – Tables 48 – Figures 352 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121632939

IHC Market growth is largely driven by the rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests. However, the high degree of consolidation in the by the major market players is expected to restrain the growth of this market during the forecast period.

The Kits product segment accounted for the highest growth rate in the immunohistochemistry market, by product, during the forecast period.

In 2020, the Kits product segment accounted for the share of around 12% of the immunohistochemsitry market. The demand for complete solutions from a single provider, like closed-system reagents with calibrated measurements of the required quantity of reagents and controls among diagnostic laboratories, hospitals, research institutes, and other end users, is growing. Moreover, ready-to-use kits simplify the IHC process by rectifying the initial time-consuming selections of primary antibodies and appropriate stains. This is fueling the growth of the immunohistochemistry kits market.

Diagnostic applications segment accounted for the largest share of the application segment.

Based on application, the IHC market is segmented into diagnostic, research, and forensic applications. The Diagnostic application segment dominated this market in 2020 and is estimated to register the highest growth during the forecast period. The growth of this segment is majorly attributed to factors such as the advantages of IHC over traditionally used special enzyme staining techniques that identify only a limited number of proteins, enzymes, and tissue structures. Therefore, IHC has become a crucial technique and is widely used for medical research as well as clinical diagnostics.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121632939

Hospitals & Diagnostic Laboratories segment accounted for the largest share of the end user segment.

Based on end user, the IHC market is segmented into hospitals & diagnostic laboratories, academic & research institutes, and other end users. The hospitals & diagnostic laboratories segment accounted for the largest share (74.8%) of the market in 2020. The increasing number of specialty diagnostic tests performed in hospital laboratories, the rising number of in-house diagnostic procedures in hospitals, and the increasing trend of establishing in-house diagnostic capabilities in hospitals to provide time-bound and affordable patient services are factors driving the growth of this market segment.

Asia Pacific: The fastest-growing region in the immunohistochemistry market.

Based on the region, the immunohistochemistry market is broadly segmented into North America, Europe, Asia-Pacific and Rest of the World. APAC is expected to register the fastest growth rate during the forecast period owing to several factors, including increasing disposable income, rising healthcare spending, growing demand for quality medical care, and increasing investments by pharmaceutical and biopharmaceutical companies. The rising prevalence of chronic ailments, rapidly increasing geriatric population, growing academic and government investments in diagnostic research, and the presence of many market players are the other major factors driving the growth of the ihc market in APAC.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121632939

Prominent players operating in the global immunohistochemistry market include F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US).

[rahulg1122]

The prosthetic heart valve market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9%.